Sierra Summit Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Buy |
16,248
+4,673
| +40% | +$3.64M | 2.25% | 14 |
|
|
2025
Q1 | $9.56M | Buy |
11,575
+719
| +7% | +$594K | 2.07% | 15 |
|
|
2024
Q4 | $8.38M | Buy |
10,856
+1,767
| +19% | +$1.36M | 1.68% | 27 |
|
|
2024
Q3 | $8.05M | Buy |
9,089
+190
| +2% | +$168K | 1.85% | 22 |
|
|
2024
Q2 | $8.06M | Buy |
8,899
+559
| +7% | +$506K | 2% | 21 |
|
|
2024
Q1 | $6.49M | Buy |
8,340
+1,948
| +30% | +$1.52M | 1.77% | 25 |
|
|
2023
Q4 | $3.73M | Buy |
+6,392
| New | +$3.73M | 1.09% | 35 |
|